Neogen Corporation

NEOGNASDAQHealthcare● Active

$9.13

+$0.23(+2.57%)

Market Cap$2.0B

P/E Ratio—

52W High$11.43

52W Low$4.56

Avg Volume2.6M

Open$8.96

Beta1.80

Free Cash Flow Financials Revenue

Neogen Corporation (NEOG) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

NEOG · free cash flow · updated Jun 8, 2026

Core FCF metrics

NEOG · FCF · TTM · margin & CAGR

Free cash flow was −$46.4M for FY2025 (fiscal year ending 2025-05-31), up 39.1% year-over-year The FCF margin was -5.2%.

FY2025 Free Cash Flow−$46.4M▲ +39.1% YoY

Trailing 12M (TTM)$41.8MTrailing 4Q sum · TTM positive vs latest FY negative

FCF Margin-5.2%−$46.4M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

NEOG · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$58.2M(105M)−$46.4M▲ +39.1%-5.2%

FY2024$35.3M(111M)−$76.2M▼ 208.0%-8.2%

FY2023$41.0M(66M)−$24.7M▼ 156.7%-3.0%

FY2022$68.0M(24M)$43.6M▼ 19.8%8.3%

FY2021$81.1M(27M)$54.4M▼ 12.0%11.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

NEOG · P/FCF · FCF yield · FCF per share

Neogen Corporation (NEOG) trades at a FCF yield of 2.16% and a price-to-free-cash-flow ratio of 48.0x. FCF per share stands at $0.19, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

2.16%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.19

TTM FCF ÷ Shares Outstanding

Price / FCF

x48.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x42.5

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-05-31

Cash flow statement summary

NEOG · cash flow statement · operating / investing / financing

For FY2025, Neogen Corporation generated $58.2M in operating cash flow and spent 105M in capital expenditures, yielding −$46.4M in free cash flow.

Operating Activities

+$58.2M

Cash from core business operations

2025-05-31

Investing Activities

−$99.2M

CapEx, acquisitions & investments

2025-05-31

Financing Activities

−$1.6M

Buybacks, dividends & debt

2025-05-31

FCF FormulaOperating CF ($58.2M) − |CapEx| (105M) = FCF (−$46.4M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

NEOG vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Neogen CorporationYOU

NEOG

−$46.4M+39.1%-5.2%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Neogen Corporation (NEOG) reported free cash flow of −$46.4M for FY2025 (fiscal year ending 2025-05-31), up 39.1% year-over-year. The FCF margin was -5.2%.

Based on available data, Neogen Corporation has maintained positive free cash flow for at least 12 fiscal year(s). FCF peaked at $61.8M in FY2020.

Neogen Corporation's FCF yield is 2.16% and price-to-FCF ratio is 48.0x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

NEOG free cash flow · 8 questions

Neogen Corporation free cash flow was −$46.4M for FY2025, up 39.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $41.8M.

NEOG free cash flowNEOG FCFNEOG FCF 2025NEOG free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Neogen Corporation · Neogen Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026